GPT and COVID-19: Only 2 or 326 (0.6%) COVID-19 cases exhibited hepatic organ dysfunction in the form of raised aspartate aminotransferase (range 63–104 U/L) and alanine aminotransferase (range 104–202 U/L); these were mild cases.